In cancer biology, NOX4 plays a dual role: while physiological ROS signaling supports normal cellular processes, pathological NOX4-driven ROS production contributes to genomic instability, tumor progression, and resistance to targeted therapies [23]. This evidence concerns the gene NOX4 and cancer.